Filing Details
- Accession Number:
- 0001179110-13-012812
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-07 17:52:44
- Reporting Period:
- 2013-08-05
- Filing Date:
- 2013-08-07
- Accepted Time:
- 2013-08-07 17:52:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1199632 | J William Bolt | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Svp, Qa And Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock $.01 Par | Acquisiton | 2013-08-05 | 18,000 | $12.30 | 118,718 | No | 4 | M | Direct | |
Common Stock, $.01 Par | Disposition | 2013-08-05 | 18,000 | $22.67 | 100,718 | No | 4 | S | Direct | |
Common Stock $.01 Par | Disposition | 2013-08-05 | 2,166 | $23.03 | 98,552 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-08-05 | 18,000 | $0.00 | 18,000 | $12.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-07-01 | 2014-07-01 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $9.36 | 2006-06-08 | 2015-06-08 | 30,000 | 30,000 | Direct |
Common Stock | Stock Option (right to buy) | $13.57 | 2007-06-01 | 2016-06-01 | 20,000 | 20,000 | Direct |
Common Stock | Stock Option (right to buy) | $11.27 | 2008-05-30 | 2017-05-30 | 8,000 | 8,000 | Direct |
Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 32,000 | 32,000 | Direct |
Common Stock | Stock Option (right to buy) | $5.86 | 2010-03-31 | 2019-05-28 | 18,000 | 18,000 | Direct |
Common Stock | Stock option (right to buy) | $13.80 | 2009-05-23 | 2018-05-23 | 9,666 | 9,666 | Direct |
Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 30,000 | 25,000 | Direct |
Common Stock | Stock Option (right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 20,000 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2024-05-14 | 20,000 | 20,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2015-06-08 | 30,000 | 30,000 | Direct |
2016-06-01 | 20,000 | 20,000 | Direct |
2017-05-30 | 8,000 | 8,000 | Direct |
2019-05-28 | 32,000 | 32,000 | Direct |
2019-05-28 | 18,000 | 18,000 | Direct |
2018-05-23 | 9,666 | 9,666 | Direct |
2020-06-03 | 30,000 | 25,000 | Direct |
2022-05-22 | 20,000 | 20,000 | Direct |
2024-05-14 | 20,000 | 20,000 | Direct |
Footnotes
- Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $22.5200 and $23.0800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $23.0000 and $23.1200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.